Skip to content
2000
Volume 20, Issue 4
  • ISSN: 1574-8928
  • E-ISSN: 2212-3970

Abstract

Background

As a binding protein of Ki67, NIFK plays an important role in the mitosis of cells and is closely related to the progression of specific types of tumors. However, there is still a lack of systematic analysis of NIFK in pan-cancer and insufficient research to explore its role in human tumors.

Methods

We systematically evaluated the pan-cancer expression and mutation of NIFK in human cancers using data from The Cancer Genome Atlas (TCGA) through large-scale bioinformatics analysis. In addition, we explored the pan-cancer immunological characteristics of NIFK, especially in colorectal adenocarcinoma (COAD). Furthermore, we used single-cell sequencing to analyze the expression of NIFK in different cells of COAD tissues and performed GO, KEGG, and gene set enrichment analysis of NIFK in COAD. Lastly, we evaluated the effects of NIFK knockdown on the colorectal cancer cell lines in experiment.

Results

We found that NIFK was overexpressed in almost all types of tumors and showed significant prognostic efficacy. Additionally, correlations between NIFK and specific immune features, such as immune cell infiltration, immune checkpoint genes, TMB, and MSI, suggest that NIFK may be used to guide immunotherapy. Subsequently, it was found that the expression of NIFK was significantly upregulated in tumor cells through single-cell sequencing analysis, and the NIFK gene was closely associated with tumor progression and immune therapy response. Finally, we further elucidated the role of NIFK in colorectal cancer and found that downregulation of NIFK expression could inhibit the proliferation, migration, and invasion ability of colorectal cancer cells.

Conclusion

The results of this study demonstrated that NIFK, as a member of the pan-cancer genes, will serve as a biomarker and a potential therapeutic target for a range of cancer types, providing new insight into precision medicine.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/pra/10.2174/0115748928295346240406185103
2024-04-24
2025-12-25

  • From This Site

    /content/journals/pra/10.2174/0115748928295346240406185103
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. SiegelR.L. MillerK.D. WagleN.S. JemalA. Cancer statistics, 2023.CA Cancer J. Clin.2023731174810.3322/caac.2176336633525
     [Google Scholar]
  2. SungH. FerlayJ. SiegelR.L. LaversanneM. SoerjomataramI. JemalA. BrayF. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J. Clin.202171320924910.3322/caac.2166033538338
     [Google Scholar]
  3. SchoenfeldA.J. HellmannM.D. Acquired resistance to immune checkpoint inhibitors.Cancer Cell202037444345510.1016/j.ccell.2020.03.01732289269
     [Google Scholar]
  4. DuY. ZhangD. WangY. WuM. ZhangC. ZhengY. ZhengA. LiuX. A highly stable multifunctional aptamer for enhancing antitumor immunity against hepatocellular carcinoma by blocking dual immune checkpoints.Biomater. Sci.20219114159416810.1039/D0BM02210A33970170
     [Google Scholar]
  5. NishimuraC.D. PulancoM.C. CuiW. LuL. ZangX. PD-L1 and B7-1 cis-interaction: New mechanisms in immune checkpoints and immunotherapies.Trends Mol. Med.202127320721910.1016/j.molmed.2020.10.00433199209
     [Google Scholar]
  6. HornL.A. FousekK. PalenaC. Tumor plasticity and resistance to immunotherapy.Trends Cancer20206543244110.1016/j.trecan.2020.02.00132348738
     [Google Scholar]
  7. PetroniG. BuquéA. ZitvogelL. KroemerG. GalluzziL. Immunomodulation by targeted anticancer agents.Cancer Cell202139331034510.1016/j.ccell.2020.11.00933338426
     [Google Scholar]
  8. SanmamedM.F. ChesterC. MeleroI. KohrtH. Defining the optimal murine models to investigate immune checkpoint blockers and their combination with other immunotherapies.Ann. Oncol.20162771190119810.1093/annonc/mdw04126912558
     [Google Scholar]
  9. PangK. ShiZ.D. WeiL.Y. DongY. MaY.Y. WangW. WangG.Y. CaoM.Y. DongJ.J. ChenY.A. ZhangP. HaoL. XuH. PanD. ChenZ.S. HanC.H. Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1/PD-L1 blockade.Drug Resist. Updat.20236610090710.1016/j.drup.2022.10090736527888
     [Google Scholar]
  10. WangR. LiuZ. WangT. ZhangJ. LiuJ. ZhouQ. Landscape of adenosine pathway and immune checkpoint dual blockade in NSCLC: Progress in basic research and clinical application.Front. Immunol.202415132024410.3389/fimmu.2024.132024438348050
     [Google Scholar]
  11. Asare-WereheneM. TsuyoshiH. ZhangH. SalehiR. ChangC.Y. CarmonaE. LibrachC.L. Mes-MassonA.M. ChangC.C. BurgerD. YoshidaY. TsangB.K. Plasma gelsolin confers chemoresistance in ovarian cancer by resetting the relative abundance and function of macrophage subtypes.Cancers2022144103910.3390/cancers1404103935205790
     [Google Scholar]
  12. GalbánS. ApfelbaumA.A. EspinozaC. HeistK. HaleyH. BediK. LjungmanM. GalbánC.J. LukerG.D. DortM.V. RossB.D. A bifunctional MAPK/PI3K antagonist for inhibition of tumor growth and metastasis.Mol. Cancer Ther.201716112340235010.1158/1535‑7163.MCT‑17‑020728775144
     [Google Scholar]
  13. BagchiS. YuanR. Englemane.g. Immune checkpoint inhibitors for the treatment of cancer: Clinical impact and mechanisms of response and resistance.Annu. Rev. Pathol.202116122324910.1146/annurev‑pathol‑042020‑04274133197221
     [Google Scholar]
  14. ThorssonV. GibbsD.L. BrownS.D. WolfD. BortoneD.S. Ou YangT.H. Porta-PardoE. GaoG.F. PlaisierC.L. EddyJ.A. ZivE. CulhaneA.C. PaullE.O. SivakumarI.K.A. GentlesA.J. MalhotraR. FarshidfarF. ColapricoA. ParkerJ.S. MoseL.E. VoN.S. LiuJ. LiuY. RaderJ. DhankaniV. ReynoldsS.M. BowlbyR. CalifanoA. CherniackA.D. AnastassiouD. BedognettiD. MokrabY. NewmanA.M. RaoA. ChenK. KrasnitzA. HuH. MaltaT.M. NoushmehrH. PedamalluC.S. BullmanS. OjesinaA.I. LambA. ZhouW. ShenH. ChoueiriT.K. WeinsteinJ.N. GuinneyJ. SaltzJ. HoltR.A. RabkinC.S. LazarA.J. SerodyJ.S. Demicco e.g. DisisM.L. VincentB.G. ShmulevichI. Caesar-JohnsonS.J. DemchokJ.A. FelauI. KasapiM. FergusonM.L. HutterC.M. SofiaH.J. TarnuzzerR. WangZ. YangL. ZenklusenJ.C. ZhangJ.J. ChudamaniS. LiuJ. LollaL. NareshR. PihlT. SunQ. WanY. WuY. ChoJ. DeFreitasT. FrazerS. GehlenborgN. GetzG. HeimanD.I. KimJ. LawrenceM.S. LinP. MeierS. NobleM.S. SaksenaG. VoetD. ZhangH. BernardB. ChambweN. DhankaniV. KnijnenburgT. KramerR. LeinonenK. LiuY. MillerM. ReynoldsS. ShmulevichI. ThorssonV. ZhangW. AkbaniR. BroomB.M. HegdeA.M. JuZ. KanchiR.S. KorkutA. LiJ. LiangH. LingS. LiuW. LuY. MillsG.B. NgK-S. RaoA. RyanM. WangJ. WeinsteinJ.N. ZhangJ. AbeshouseA. ArmeniaJ. ChakravartyD. ChatilaW.K. de BruijnI. GaoJ. GrossB.E. HeinsZ.J. KundraR. LaK. LadanyiM. LunaA. NissanM.G. OchoaA. PhillipsS.M. ReznikE. Sanchez-VegaF. SanderC. SchultzN. SheridanR. SumerS.O. SunY. TaylorB.S. WangJ. ZhangH. AnurP. PetoM. SpellmanP. BenzC. StuartJ.M. WongC.K. YauC. HayesD.N. ParkerJ.S. WilkersonM.D. AllyA. BalasundaramM. BowlbyR. BrooksD. CarlsenR. ChuahE. DhallaN. HoltR. JonesS.J.M. KasaianK. LeeD. MaY. MarraM.A. MayoM. MooreR.A. MungallA.J. MungallK. RobertsonA.G. SadeghiS. ScheinJ.E. SipahimalaniP. TamA. ThiessenN. TseK. WongT. BergerA.C. BeroukhimR. CherniackA.D. CibulskisC. GabrielS.B. GaoG.F. HaG. MeyersonM. SchumacherS.E. ShihJ. KucherlapatiM.H. KucherlapatiR.S. BaylinS. CopeL. DanilovaL. BootwallaM.S. LaiP.H. MaglinteD.T. Van Den BergD.J. WeisenbergerD.J. AumanJ.T. BaluS. BodenheimerT. FanC. HoadleyK.A. HoyleA.P. JefferysS.R. JonesC.D. MengS. MieczkowskiP.A. MoseL.E. PerouA.H. PerouC.M. RoachJ. ShiY. SimonsJ.V. SkellyT. SolowayM.G. TanD. VeluvoluU. FanH. HinoueT. LairdP.W. ShenH. ZhouW. BellairM. ChangK. CovingtonK. CreightonC.J. DinhH. DoddapaneniH.V. DonehowerL.A. DrummondJ. GibbsR.A. GlennR. HaleW. HanY. HuJ. KorchinaV. LeeS. LewisL. LiW. LiuX. MorganM. MortonD. MuznyD. SantibanezJ. ShethM. ShinbrotE. WangL. WangM. WheelerD.A. XiL. ZhaoF. HessJ. AppelbaumE.L. BaileyM. CordesM.G. DingL. FronickC.C. FultonL.A. FultonR.S. KandothC. MardisE.R. McLellanM.D. MillerC.A. SchmidtH.K. WilsonR.K. CrainD. CurleyE. GardnerJ. LauK. MalleryD. MorrisS. PaulauskisJ. PennyR. SheltonC. SheltonT. ShermanM. ThompsonE. YenaP. BowenJ. Gastier-FosterJ.M. GerkenM. LeraasK.M. LichtenbergT.M. RamirezN.C. WiseL. ZmudaE. CorcoranN. CostelloT. HovensC. CarvalhoA.L. de CarvalhoA.C. FregnaniJ.H. FilhoL.A. ReisR.M. NetoS.C. SilveiraH.C.S. VidalD.O. BurnetteA. EschbacherJ. HermesB. NossA. SinghR. AndersonM.L. CastroP.D. IttmannM. HuntsmanD. KohlB. LeX. ThorpR. AndryC. DuffyE.R. LyadovV. PaklinaO. SetdikovaG. ShabuninA. TavobilovM. McPhersonC. WarnickR. BerkowitzR. CramerD. FeltmateC. HorowitzN. KibelA. MutoM. RautC.P. MalykhA. Barnholtz-SloanJ.S. BarrettW. DevineK. FulopJ. OstromQ.T. ShimmelK. WolinskyY. SloanA.E. De RoseA. GiulianteF. GoodmanM. KarlanB.Y. HagedornC.H. EckmanJ. HarrJ. MyersJ. TuckerK. ZachL.A. DeyarminB. HuH. KvecherL. LarsonC. MuralR.J. SomiariS. VichaA. ZelinkaT. BennettJ. IacoccaM. RabenoB. SwansonP. LatourM. LacombeL. TêtuB. BergeronA. McGrawM. StaugaitisS.M. ChabotJ. HibshooshH. SepulvedaA. SuT. WangT. PotapovaO. VoroninaO. DesjardinsL. MarianiO. Roman-RomanS. SastreX. SternM-H. ChengF. SignorettiS. BerchuckA. BignerD. LippE. MarksJ. McCallS. McLendonR. SecordA. SharpA. BeheraM. BratD.J. ChenA. DelmanK. ForceS. KhuriF. MaglioccaK. MaithelS. OlsonJ.J. OwonikokoT. PickensA. RamalingamS. ShinD.M. SicaG. Van Meir e.g. ZhangH. EijckenboomW. GillisA. KorpershoekE. LooijengaL. OosterhuisW. StoopH. van KesselK.E. ZwarthoffE.C. CalatozzoloC. CuppiniL. CuzzubboS. DiMecoF. FinocchiaroG. MatteiL. PerinA. PolloB. ChenC. HouckJ. LohavanichbutrP. HartmannA. StoehrC. StoehrR. TaubertH. WachS. WullichB. KyclerW. MurawaD. WiznerowiczM. ChungK. EdenfieldW.J. MartinJ. BaudinE. BubleyG. BuenoR. De RienzoA. RichardsW.G. KalkanisS. MikkelsenT. NoushmehrH. ScarpaceL. GirardN. AymerichM. CampoE. GinéE. GuillermoA.L. Van BangN. HanhP.T. PhuB.D. TangY. ColmanH. EvasonK. DottinoP.R. MartignettiJ.A. GabraH. JuhlH. AkeredoluT. StepaS. HoonD. AhnK. KangK.J. BeuschleinF. BreggiaA. BirrerM. BellD. BoradM. BryceA.H. CastleE. ChandanV. ChevilleJ. CoplandJ.A. FarnellM. FlotteT. GiamaN. HoT. KendrickM. KocherJ-P. KoppK. MoserC. NagorneyD. O’BrienD. O’NeillB.P. PatelT. PetersenG. QueF. RiveraM. RobertsL. SmallridgeR. SmyrkT. StantonM. ThompsonR.H. TorbensonM. YangJ.D. ZhangL. BrimoF. AjaniJ.A. GonzalezA.M.A. BehrensC. BondarukJ. BroaddusR. CzerniakB. EsmaeliB. FujimotoJ. GershenwaldJ. GuoC. LazarA.J. LogothetisC. Meric-BernstamF. MoranC. RamondettaL. RiceD. SoodA. TamboliP. ThompsonT. TroncosoP. TsaoA. WistubaI. CarterC. HayduL. HerseyP. JakrotV. KakavandH. KeffordR. LeeK. LongG. MannG. QuinnM. SawR. ScolyerR. ShannonK. SpillaneA. Stretch SynottM. ThompsonJ. WilmottJ. Al-AhmadieH. ChanT.A. GhosseinR. GopalanA. LevineD.A. ReuterV. SingerS. SinghB. TienN.V. BroudyT. MirsaidiC. NairP. DrwiegaP. MillerJ. SmithJ. ZarenH. ParkJ-W. HungN.P. KebebewE. LinehanW.M. MetwalliA.R. PacakK. PintoP.A. SchiffmanM. SchmidtL.S. VockeC.D. WentzensenN. WorrellR. YangH. MoncrieffM. GoparajuC. MelamedJ. PassH. BotnariucN. CaramanI. CernatM. ChemencedjiI. ClipcaA. DorucS. GorincioiG. MuraS. PirtacM. StanculI. TcaciucD. AlbertM. AlexopoulouI. ArnaoutA. BartlettJ. EngelJ. GilbertS. ParfittJ. SekhonH. ThomasG. RasslD.M. RintoulR.C. BifulcoC. TamakawaR. UrbaW. HaywardN. TimmersH. AntenucciA. FaccioloF. GraziG. MarinoM. MerolaR. de KrijgerR. Gimenez-RoqueploA-P. PichéA. ChevalierS. McKercherG. BirsoyK. BarnettG. BrewerC. FarverC. NaskaT. PennellN.A. RaymondD. SchileroC. SmolenskiK. WilliamsF. MorrisonC. BorgiaJ.A. LiptayM.J. PoolM. SederC.W. JunkerK. OmbergL. DinkinM. ManikhasG. AlvaroD. BragazziM.C. CardinaleV. CarpinoG. GaudioE. CheslaD. CottinghamS. DubinaM. MoiseenkoF. DhanasekaranR. BeckerK-F. JanssenK-P. Slotta-HuspeninaJ. Abdel-RahmanM.H. AzizD. BellS. CebullaC.M. DavisA. DuellR. ElderJ.B. HiltyJ. KumarB. LangJ. LehmanN.L. MandtR. NguyenP. PilarskiR. RaiK. SchoenfieldL. SenecalK. WakelyP. HansenP. LechanR. PowersJ. TischlerA. GrizzleW.E. SextonK.C. KastlA. HendersonJ. PortenS. WaldmannJ. FassnachtM. AsaS.L. SchadendorfD. CouceM. GraefenM. HulandH. SauterG. SchlommT. SimonR. TennstedtP. OlabodeO. NelsonM. BatheO. CarrollP.R. ChanJ.M. DisaiaP. GlennP. KelleyR.K. LandenC.N. PhillipsJ. PradosM. SimkoJ. Smith-McCuneK. VandenBergS. RogginK. FehrenbachA. KendlerA. SifriS. SteeleR. JimenoA. CareyF. ForgieI. MannelliM. CarneyM. HernandezB. CamposB. Herold-MendeC. JungkC. UnterbergA. von DeimlingA. BosslerA. GalbraithJ. JacobusL. KnudsonM. KnutsonT. MaD. MilhemM. SigmundR. GodwinA.K. MadanR. RosenthalH.G. AdebamowoC. AdebamowoS.N. BoussioutasA. BeerD. GiordanoT. Mes-MassonA-M. SaadF. BocklageT. LandrumL. MannelR. MooreK. MoxleyK. PostierR. WalkerJ. ZunaR. FeldmanM. ValdiviesoF. DhirR. LuketichJ. PineroE.M.M. Quintero-AguiloM. CarlottiC.G.Jr Dos SantosJ.S. KempR. SankarankutyA. TirapelliD. CattoJ. AgnewK. SwisherE. CreaneyJ. RobinsonB. ShelleyC.S. GodwinE.M. KendallS. ShipmanC. BradfordC. CareyT. HaddadA. MoyerJ. PetersonL. PrinceM. RozekL. WolfG. BowmanR. FongK.M. YangI. KorstR. RathmellW.K. CampbellF.J.L. HookeJ.A. KovatichA.J. ShriverC.D. DiPersioJ. DrakeB. GovindanR. HeathS. LeyT. Van TineB. WesterveltP. RubinM.A. LeeJ.I. AredesN.D. MariamidzeA. The immune landscape of cancer.Immunity2018484812830.e1410.1016/j.immuni.2018.03.02329628290
     [Google Scholar]
  15. ZhangY. ZhangZ. The history and advances in cancer immunotherapy: Understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications.Cell. Mol. Immunol.202017880782110.1038/s41423‑020‑0488‑632612154
     [Google Scholar]
  16. FengZ. ChenY. CaiC. TanJ. LiuP. ChenY. ShenH. ZengS. HanY. Pan-cancer and single-cell analysis reveals CENPL as a cancer prognosis and immune infiltration-related biomarker.Front. Immunol.20221391659410.3389/fimmu.2022.91659435844598
     [Google Scholar]
  17. LiZ. ChenS. FengW. LuoY. LaiH. LiQ. XiuB. LiY. LiY. HuangS. ZhuX. A pan-cancer analysis of HER2 index revealed transcriptional pattern for precise selection of HER2-targeted therapy.EBioMedicine20206210307410.1016/j.ebiom.2020.10307433161227
     [Google Scholar]
  18. SaidakZ. SoudetS. LottinM. SalleV. SevestreM.A. ClatotF. GalmicheA. A pan-cancer analysis of the human tumor coagulome and its link to the tumor immune microenvironment.Cancer Immunol. Immunother.202170492393310.1007/s00262‑020‑02739‑w33057845
     [Google Scholar]
  19. TakagiM. SueishiM. SaiwakiT. KametakaA. YonedaY. A novel nucleolar protein, NIFK, interacts with the forkhead associated domain of Ki-67 antigen in mitosis.J. Biol. Chem.200127627253862539110.1074/jbc.M10222720011342549
     [Google Scholar]
  20. LiH. ByeonI.J.L. JuY. TsaiM.D. Structure of human Ki67 FHA domain and its binding to a phosphoprotein fragment from hNIFK reveal unique recognition sites and new views to the structural basis of FHA domain functions.J. Mol. Biol.2004335137138110.1016/j.jmb.2003.10.03214659764
     [Google Scholar]
  21. LinT.C. SuC.Y. WuP.Y. LaiT.C. PanW.A. JanY.H. ChangY.C. YehC.T. ChenC.L. GerL.P. ChangH.T. YangC.J. HuangM.S. LiuY.P. LinY.F. ShyyJ.Y.J. TsaiM.D. HsiaoM. The nucleolar protein NIFK promotes cancer progression via CK1α/β-catenin in metastasis and Ki-67-dependent cell proliferation.eLife20165e1128810.7554/eLife.1128826984280
     [Google Scholar]
  22. BoothD.G. TakagiM. PulidoS.L. PetfalskiE. VargiuG. SamejimaK. ImamotoN. PontingC.P. TollerveyD. EarnshawW.C. VagnarelliP. Ki-67 is a PP1-interacting protein that organises the mitotic chromosome periphery.eLife20143e0164110.7554/eLife.0164124867636
     [Google Scholar]
  23. ByeonI.J.L. LiH. SongH. GronenbornA.M. TsaiM.D. Sequential phosphorylation and multisite interactions characterize specific target recognition by the FHA domain of Ki67.Nat. Struct. Mol. Biol.2005121198799310.1038/nsmb100816244663
     [Google Scholar]
  24. SueishiM. TakagiM. YonedaY. The forkhead-associated domain of Ki-67 antigen interacts with the novel kinesin-like protein Hklp2.J. Biol. Chem.200027537288882889210.1074/jbc.M00387920010878014
     [Google Scholar]
  25. LiQ. ChenW. LiQ. MaoJ. ChenX. A novel neutrophil extracellular trap signature to predict prognosis and immunotherapy response in head and neck squamous cell carcinoma.Front. Immunol.202213101996710.3389/fimmu.2022.101996736225931
     [Google Scholar]
  26. ShenW. SongZ. ZhongX. HuangM. ShenD. GaoP. QianX. WangM. HeX. WangT. LiS. SongX. Sangerbox: A comprehensive, interaction-friendly clinical bioinformatics analysis platform.iMeta202213e3610.1002/imt2.36
     [Google Scholar]
  27. WangD. QianX. DuY.C.N. SolanaS.B. ChenK. ParkB. ChenB. JenkinsL. LuoJ. TripathiB.K. DurkinM.E. LowyD.R. Abstract 3912: cProSite: A web based interactive platform for on-line proteomics and phosphoproteomics data analysis.Cancer Res.202282S123912391210.1158/1538‑7445.AM2022‑391235413105
     [Google Scholar]
  28. CeramiE. GaoJ. DogrusozU. GrossB.E. SumerS.O. AksoyB.A. JacobsenA. ByrneC.J. HeuerM.L. LarssonE. AntipinY. RevaB. GoldbergA.P. SanderC. SchultzN. The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data.Cancer Discov.20122540140410.1158/2159‑8290.CD‑12‑009522588877
     [Google Scholar]
  29. GaoJ. AksoyB.A. DogrusozU. DresdnerG. GrossB. SumerS.O. SunY. JacobsenA. SinhaR. LarssonE. CeramiE. SanderC. SchultzN. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal.Sci. Signal.20136269pl110.1126/scisignal.200408823550210
     [Google Scholar]
  30. MaltaT.M. SokolovA. GentlesA.J. BurzykowskiT. PoissonL. WeinsteinJ.N. KamińskaB. HuelskenJ. OmbergL. GevaertO. ColapricoA. CzerwińskaP. MazurekS. MishraL. HeynH. KrasnitzA. GodwinA.K. LazarA.J. StuartJ.M. HoadleyK.A. LairdP.W. NoushmehrH. WiznerowiczM. Caesar-JohnsonS.J. DemchokJ.A. FelauI. KasapiM. FergusonM.L. HutterC.M. SofiaH.J. TarnuzzerR. WangZ. YangL. ZenklusenJ.C. ZhangJ.J. ChudamaniS. LiuJ. LollaL. NareshR. PihlT. SunQ. WanY. WuY. ChoJ. DeFreitasT. FrazerS. GehlenborgN. GetzG. HeimanD.I. KimJ. LawrenceM.S. LinP. MeierS. NobleM.S. SaksenaG. VoetD. ZhangH. BernardB. ChambweN. DhankaniV. KnijnenburgT. KramerR. LeinonenK. LiuY. MillerM. ReynoldsS. ShmulevichI. ThorssonV. ZhangW. AkbaniR. BroomB.M. HegdeA.M. JuZ. KanchiR.S. KorkutA. LiJ. LiangH. LingS. LiuW. LuY. MillsG.B. NgK-S. RaoA. RyanM. WangJ. WeinsteinJ.N. ZhangJ. AbeshouseA. ArmeniaJ. ChakravartyD. ChatilaW.K. de BruijnI. GaoJ. GrossB.E. HeinsZ.J. KundraR. LaK. LadanyiM. LunaA. NissanM.G. OchoaA. PhillipsS.M. ReznikE. Sanchez-VegaF. SanderC. SchultzN. SheridanR. SumerS.O. SunY. TaylorB.S. WangJ. ZhangH. AnurP. PetoM. SpellmanP. BenzC. StuartJ.M. WongC.K. YauC. HayesD.N. ParkerJ.S. WilkersonM.D. AllyA. BalasundaramM. BowlbyR. BrooksD. CarlsenR. ChuahE. DhallaN. HoltR. JonesS.J.M. KasaianK. LeeD. MaY. MarraM.A. MayoM. MooreR.A. MungallA.J. MungallK. RobertsonA.G. SadeghiS. ScheinJ.E. SipahimalaniP. TamA. ThiessenN. TseK. WongT. BergerA.C. BeroukhimR. CherniackA.D. CibulskisC. GabrielS.B. GaoG.F. HaG. MeyersonM. SchumacherS.E. ShihJ. KucherlapatiM.H. KucherlapatiR.S. BaylinS. CopeL. DanilovaL. BootwallaM.S. LaiP.H. MaglinteD.T. Van Den BergD.J. WeisenbergerD.J. AumanJ.T. BaluS. BodenheimerT. FanC. HoadleyK.A. HoyleA.P. JefferysS.R. JonesC.D. MengS. MieczkowskiP.A. MoseL.E. PerouA.H. PerouC.M. RoachJ. ShiY. SimonsJ.V. SkellyT. SolowayM.G. TanD. VeluvoluU. FanH. HinoueT. LairdP.W. ShenH. ZhouW. BellairM. ChangK. CovingtonK. CreightonC.J. DinhH. DoddapaneniH.V. DonehowerL.A. DrummondJ. GibbsR.A. GlennR. HaleW. HanY. HuJ. KorchinaV. LeeS. LewisL. LiW. LiuX. MorganM. MortonD. MuznyD. SantibanezJ. ShethM. ShinbrotE. WangL. WangM. WheelerD.A. XiL. ZhaoF. HessJ. AppelbaumE.L. BaileyM. CordesM.G. DingL. FronickC.C. FultonL.A. FultonR.S. KandothC. MardisE.R. McLellanM.D. MillerC.A. SchmidtH.K. WilsonR.K. CrainD. CurleyE. GardnerJ. LauK. MalleryD. MorrisS. PaulauskisJ. PennyR. SheltonC. SheltonT. ShermanM. ThompsonE. YenaP. BowenJ. FosterG.J.M. GerkenM. LeraasK.M. LichtenbergT.M. RamirezN.C. WiseL. ZmudaE. CorcoranN. CostelloT. HovensC. CarvalhoA.L. de CarvalhoA.C. FregnaniJ.H. FilhoL.A. ReisR.M. NetoS.C. SilveiraH.C.S. VidalD.O. BurnetteA. EschbacherJ. HermesB. NossA. SinghR. AndersonM.L. CastroP.D. IttmannM. HuntsmanD. KohlB. LeX. ThorpR. AndryC. DuffyE.R. LyadovV. PaklinaO. SetdikovaG. ShabuninA. TavobilovM. McPhersonC. WarnickR. BerkowitzR. CramerD. FeltmateC. HorowitzN. KibelA. MutoM. RautC.P. MalykhA. SloanB.J.S. BarrettW. DevineK. FulopJ. OstromQ.T. ShimmelK. WolinskyY. SloanA.E. De RoseA. GiulianteF. GoodmanM. KarlanB.Y. HagedornC.H. EckmanJ. HarrJ. MyersJ. TuckerK. ZachL.A. DeyarminB. HuH. KvecherL. LarsonC. MuralR.J. SomiariS. VichaA. ZelinkaT. BennettJ. IacoccaM. RabenoB. SwansonP. LatourM. LacombeL. TêtuB. BergeronA. McGrawM. StaugaitisS.M. ChabotJ. HibshooshH. SepulvedaA. SuT. WangT. PotapovaO. VoroninaO. DesjardinsL. MarianiO. Roman-RomanS. SastreX. SternM-H. ChengF. SignorettiS. BerchuckA. BignerD. LippE. MarksJ. McCallS. McLendonR. SecordA. SharpA. BeheraM. BratD.J. ChenA. DelmanK. ForceS. KhuriF. MaglioccaK. MaithelS. OlsonJ.J. OwonikokoT. PickensA. RamalingamS. ShinD.M. SicaG. Van Meir e.g. ZhangH. EijckenboomW. GillisA. KorpershoekE. LooijengaL. OosterhuisW. StoopH. van KesselK.E. ZwarthoffE.C. CalatozzoloC. CuppiniL. CuzzubboS. DiMecoF. FinocchiaroG. MatteiL. PerinA. PolloB. ChenC. HouckJ. LohavanichbutrP. HartmannA. StoehrC. StoehrR. TaubertH. WachS. WullichB. KyclerW. MurawaD. WiznerowiczM. ChungK. EdenfieldW.J. MartinJ. BaudinE. BubleyG. BuenoR. De RienzoA. RichardsW.G. KalkanisS. MikkelsenT. NoushmehrH. ScarpaceL. GirardN. AymerichM. CampoE. GinéE. GuillermoA.L. Van BangN. HanhP.T. PhuB.D. TangY. ColmanH. EvasonK. DottinoP.R. MartignettiJ.A. GabraH. JuhlH. AkeredoluT. StepaS. HoonD. AhnK. KangK.J. BeuschleinF. BreggiaA. BirrerM. BellD. BoradM. BryceA.H. CastleE. ChandanV. ChevilleJ. CoplandJ.A. FarnellM. FlotteT. GiamaN. HoT. KendrickM. KocherJ-P. KoppK. MoserC. NagorneyD. O’BrienD. O’NeillB.P. PatelT. PetersenG. QueF. RiveraM. RobertsL. SmallridgeR. SmyrkT. StantonM. ThompsonR.H. TorbensonM. YangJ.D. ZhangL. BrimoF. AjaniJ.A. GonzalezA.M.A. BehrensC. BondarukJ. BroaddusR. CzerniakB. EsmaeliB. FujimotoJ. GershenwaldJ. GuoC. LazarA.J. LogothetisC. Meric-BernstamF. MoranC. RamondettaL. RiceD. SoodA. TamboliP. ThompsonT. TroncosoP. TsaoA. WistubaI. CarterC. HayduL. HerseyP. JakrotV. KakavandH. KeffordR. LeeK. LongG. MannG. QuinnM. SawR. ScolyerR. ShannonK. SpillaneA. StretchJ. SynottM. ThompsonJ. WilmottJ. Al-AhmadieH. ChanT.A. GhosseinR. GopalanA. LevineD.A. ReuterV. SingerS. SinghB. TienN.V. BroudyT. MirsaidiC. NairP. DrwiegaP. MillerJ. SmithJ. ZarenH. ParkJ-W. HungN.P. KebebewE. LinehanW.M. MetwalliA.R. PacakK. PintoP.A. SchiffmanM. SchmidtL.S. VockeC.D. WentzensenN. WorrellR. YangH. MoncrieffM. GoparajuC. MelamedJ. PassH. BotnariucN. CaramanI. CernatM. ChemencedjiI. ClipcaA. DorucS. GorincioiG. MuraS. PirtacM. StanculI. TcaciucD. AlbertM. AlexopoulouI. ArnaoutA. BartlettJ. EngelJ. GilbertS. ParfittJ. SekhonH. ThomasG. RasslD.M. RintoulR.C. BifulcoC. TamakawaR. UrbaW. HaywardN. TimmersH. AntenucciA. FaccioloF. GraziG. MarinoM. MerolaR. de KrijgerR. RoqueploG.A.P. PichéA. ChevalierS. McKercherG. BirsoyK. BarnettG. BrewerC. FarverC. NaskaT. PennellN.A. RaymondD. SchileroC. SmolenskiK. WilliamsF. MorrisonC. BorgiaJ.A. LiptayM.J. PoolM. SederC.W. JunkerK. OmbergL. DinkinM. ManikhasG. AlvaroD. BragazziM.C. CardinaleV. CarpinoG. GaudioE. CheslaD. CottinghamS. DubinaM. MoiseenkoF. DhanasekaranR. BeckerK-F. JanssenK-P. Slotta-HuspeninaJ. Abdel-RahmanM.H. AzizD. BellS. CebullaC.M. DavisA. DuellR. ElderJ.B. HiltyJ. KumarB. LangJ. LehmanN.L. MandtR. NguyenP. PilarskiR. RaiK. SchoenfieldL. SenecalK. WakelyP. HansenP. LechanR. PowersJ. TischlerA. GrizzleW.E. SextonK.C. KastlA. HendersonJ. PortenS. WaldmannJ. FassnachtM. AsaS.L. SchadendorfD. CouceM. GraefenM. HulandH. SauterG. SchlommT. SimonR. TennstedtP. OlabodeO. NelsonM. BatheO. CarrollP.R. ChanJ.M. DisaiaP. GlennP. KelleyR.K. LandenC.N. PhillipsJ. PradosM. SimkoJ. Smith-McCuneK. VandenBergS. RogginK. FehrenbachA. KendlerA. SifriS. SteeleR. JimenoA. CareyF. ForgieI. MannelliM. CarneyM. HernandezB. CamposB. Herold-MendeC. JungkC. UnterbergA. von DeimlingA. BosslerA. GalbraithJ. JacobusL. KnudsonM. KnutsonT. MaD. MilhemM. SigmundR. GodwinA.K. MadanR. RosenthalH.G. AdebamowoC. AdebamowoS.N. BoussioutasA. BeerD. GiordanoT. Mes-MassonA-M. SaadF. BocklageT. LandrumL. MannelR. MooreK. MoxleyK. PostierR. WalkerJ. ZunaR. FeldmanM. ValdiviesoF. DhirR. LuketichJ. PineroE.M.M. AguiloQ.M. CarlottiC.G.Jr Dos SantosJ.S. KempR. SankarankutyA. TirapelliD. CattoJ. AgnewK. SwisherE. CreaneyJ. RobinsonB. ShelleyC.S. GodwinE.M. KendallS. ShipmanC. BradfordC. CareyT. HaddadA. MoyerJ. PetersonL. PrinceM. RozekL. WolfG. BowmanR. FongK.M. YangI. KorstR. RathmellW.K. CampbellF.J.L. HookeJ.A. KovatichA.J. ShriverC.D. DiPersioJ. DrakeB. GovindanR. HeathS. LeyT. Van TineB. WesterveltP. RubinM.A. LeeJ.I. AredesN.D. MariamidzeA. Machine learning identifies stemness features associated with oncogenic dedifferentiation.Cell20181732338354.e1510.1016/j.cell.2018.03.03429625051
     [Google Scholar]
  31. LiT. FuJ. ZengZ. CohenD. LiJ. ChenQ. LiB. LiuX.S. TIMER2.0 for analysis of tumor-infiltrating immune cells.Nucleic Acids Res.202048W1W509W51410.1093/nar/gkaa40732442275
     [Google Scholar]
  32. NewmanA.M. LiuC.L. GreenM.R. GentlesA.J. FengW. XuY. HoangC.D. DiehnM. AlizadehA.A. Robust enumeration of cell subsets from tissue expression profiles.Nat. Methods201512545345710.1038/nmeth.333725822800
     [Google Scholar]
  33. FinotelloF. MayerC. PlattnerC. LaschoberG. RiederD. HacklH. KrogsdamA. LoncovaZ. PoschW. WilflingsederD. SopperS. IjsselsteijnM. BrouwerT.P. JohnsonD. XuY. WangY. SandersM.E. EstradaM.V. GonzalezE.P. CharoentongP. BalkoJ. de MirandaN.F.C.C. TrajanoskiZ. Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data.Genome Med.20191113410.1186/s13073‑019‑0638‑631126321
     [Google Scholar]
  34. BechtE. GiraldoN.A. LacroixL. ButtardB. ElarouciN. PetitprezF. SelvesJ. Laurent-PuigP. Sautès-FridmanC. FridmanW.H. de ReynièsA. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression.Genome Biol.201617121810.1186/s13059‑016‑1070‑527765066
     [Google Scholar]
  35. AranD. HuZ. ButteA.J. xCell: Digitally portraying the tissue cellular heterogeneity landscape.Genome Biol.201718122010.1186/s13059‑017‑1349‑129141660
     [Google Scholar]
  36. RacleJ. de JongeK. BaumgaertnerP. SpeiserD.E. GfellerD. Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data.eLife20176e2647610.7554/eLife.2647629130882
     [Google Scholar]
  37. ZengD. YeZ. ShenR. YuG. WuJ. XiongY. ZhouR. QiuW. HuangN. SunL. LiX. BinJ. LiaoY. ShiM. LiaoW. IOBR: Multi-omics immuno-oncology biological research to decode tumor microenvironment and signatures.Front. Immunol.20211268797510.3389/fimmu.2021.68797534276676
     [Google Scholar]
  38. YuG. WangL.G. HanY. HeQ.Y. clusterProfiler: An R package for comparing biological themes among gene clusters.OMICS201216528428710.1089/omi.2011.011822455463
     [Google Scholar]
  39. SubramanianA. TamayoP. MoothaV.K. MukherjeeS. EbertB.L. GilletteM.A. PaulovichA. PomeroyS.L. GolubT.R. LanderE.S. MesirovJ.P. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles.Proc. Natl. Acad. Sci.200510243155451555010.1073/pnas.050658010216199517
     [Google Scholar]
  40. GoodmanA.M. SokolE.S. FramptonG.M. LippmanS.M. KurzrockR. Microsatellite-stable tumors with high mutational burden benefit from immunotherapy.Cancer Immunol. Res.20197101570157310.1158/2326‑6066.CIR‑19‑014931405947
     [Google Scholar]
  41. PicardE. VerschoorC.P. MaG.W. PawelecG. Relationships between immune landscapes, genetic subtypes and responses to immunotherapy in colorectal cancer.Front. Immunol.20201136910.3389/fimmu.2020.0036932210966
     [Google Scholar]
  42. NamA.S. ChaligneR. LandauD.A. Integrating genetic and non-genetic determinants of cancer evolution by single-cell multi-omics.Nat. Rev. Genet.202122131810.1038/s41576‑020‑0265‑532807900
     [Google Scholar]
  43. TurajlicS. SottorivaA. GrahamT. SwantonC. Resolving genetic heterogeneity in cancer.Nat. Rev. Genet.201920740441610.1038/s41576‑019‑0114‑630918367
     [Google Scholar]
  44. HanahanD. Hallmarks of cancer: New dimensions.Cancer Discov.2022121314610.1158/2159‑8290.CD‑21‑105935022204
     [Google Scholar]
  45. HanahanD. WeinbergR.A. Hallmarks of cancer: The next generation.Cell2011144564667410.1016/j.cell.2011.02.01321376230
     [Google Scholar]
  46. AminM.B. GreeneF.L. EdgeS.B. ComptonC.C. GershenwaldJ.E. BrooklandR.K. MeyerL. GressD.M. ByrdD.R. WinchesterD.P. The Eighth Edition AJCC cancer staging manual: Continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging.CA Cancer J Clin20176729399
     [Google Scholar]
  47. ZhouY. YangD. YangQ. LvX. HuangW. ZhouZ. WangY. ZhangZ. YuanT. DingX. TangL. ZhangJ. YinJ. HuangY. YuW. WangY. ZhouC. SuY. HeA. SunY. ShenZ. QianB. MengW. FeiJ. YaoY. PanX. ChenP. HuH. Single-cell RNA landscape of intratumoral heterogeneity and immunosuppressive microenvironment in advanced osteosarcoma.Nat. Commun.2020111632210.1038/s41467‑020‑20059‑633303760
     [Google Scholar]
  48. BabadiM. FuJ.M. LeeS.K. SmirnovA.N. GauthierL.D. WalkerM. BenjaminD.I. ZhaoX. KarczewskiK.J. WongI. CollinsR.L. Sanchis-JuanA. BrandH. BanksE. TalkowskiM.E. GATK-gCNV enables the discovery of rare copy number variants from exome sequencing data.Nat. Genet.20235591589159710.1038/s41588‑023‑01449‑037604963
     [Google Scholar]
  49. MarshallC.R. HowriganD.P. MericoD. ThiruvahindrapuramB. WuW. GreerD.S. AntakiD. ShettyA. HolmansP.A. PintoD. GujralM. BrandlerW.M. MalhotraD. WangZ. FajaradoK.V.F. MaileM.S. RipkeS. AgartzI. AlbusM. AlexanderM. AminF. AtkinsJ. BacanuS.A. BelliveauR.A.Jr BergenS.E. BertalanM. BevilacquaE. BigdeliT.B. BlackD.W. BruggemanR. BuccolaN.G. BucknerR.L. Bulik-SullivanB. ByerleyW. CahnW. CaiG. CairnsM.J. CampionD. CantorR.M. CarrV.J. CarreraN. CattsS.V. ChambertK.D. ChengW. CloningerC.R. CohenD. CormicanP. CraddockN. FacorroC.B. CrowleyJ.J. CurtisD. DavidsonM. DavisK.L. DegenhardtF. Del FaveroJ. DeLisiL.E. DikeosD. DinanT. DjurovicS. DonohoeG. DrapeauE. DuanJ. DudbridgeF. EichhammerP. ErikssonJ. PriceE.V. EssiouxL. FanousA.H. FarhK.H. FarrellM.S. FrankJ. FrankeL. FreedmanR. FreimerN.B. FriedmanJ.I. ForstnerA.J. FromerM. GenoveseG. GeorgievaL. GershonE.S. GieglingI. RodríguezG.P. GodardS. GoldsteinJ.I. GrattenJ. de HaanL. HamshereM.L. HansenM. HansenT. HaroutunianV. HartmannA.M. HenskensF.A. HermsS. HirschhornJ.N. HoffmannP. HofmanA. HuangH. IkedaM. JoaI. KählerA.K. KahnR.S. KalaydjievaL. KarjalainenJ. KavanaghD. KellerM.C. KellyB.J. KennedyJ.L. KimY. KnowlesJ.A. KonteB. LaurentC. LeeP. LeeS.H. LeggeS.E. LererB. LevyD.L. LiangK.Y. LiebermanJ. LönnqvistJ. LoughlandC.M. MagnussonP.K.E. MaherB.S. MaierW. MalletJ. MattheisenM. MattingsdalM. McCarleyR.W. McDonaldC. McIntoshA.M. MeierS. MeijerC.J. MelleI. GatelyM.R.I. MetspaluA. MichieP.T. MilaniL. MilanovaV. MokrabY. MorrisD.W. MyhsokM.B. MurphyK.C. MurrayR.M. GermeysM.I. NenadicI. NertneyD.A. NestadtG. NicodemusK.K. NisenbaumL. NordinA. O’CallaghanE. O’DushlaineC. OhS.Y. OlincyA. OlsenL. O’NeillF.A. Van OsJ. PantelisC. PapadimitriouG.N. ParkhomenkoE. PatoM.T. PaunioT. PerkinsD.O. PersT.H. PietiläinenO. PimmJ. PocklingtonA.J. PowellJ. PriceA. PulverA.E. PurcellS.M. QuestedD. RasmussenH.B. ReichenbergA. ReimersM.A. RichardsA.L. RoffmanJ.L. RoussosP. RuderferD.M. SalomaaV. SandersA.R. SavitzA. SchallU. SchulzeT.G. SchwabS.G. ScolnickE.M. ScottR.J. SeidmanL.J. ShiJ. SilvermanJ.M. SmollerJ.W. SödermanE. SpencerC.C.A. StahlE.A. StrengmanE. StrohmaierJ. StroupT.S. SuvisaariJ. SvrakicD.M. SzatkiewiczJ.P. ThirumalaiS. TooneyP.A. VeijolaJ. VisscherP.M. WaddingtonJ. WalshD. WebbB.T. WeiserM. WildenauerD.B. WilliamsN.M. WilliamsS. WittS.H. WolenA.R. WormleyB.K. WrayN.R. WuJ.Q. ZaiC.C. AdolfssonR. AndreassenO.A. BlackwoodD.H.R. BramonE. BuxbaumJ.D. CichonS. CollierD.A. CorvinA. DalyM.J. DarvasiA. DomeniciE. EskoT. GejmanP.V. GillM. GurlingH. HultmanC.M. IwataN. JablenskyA.V. Jönsson e.g. KendlerK.S. KirovG. KnightJ. LevinsonD.F. LiQ.S. McCarrollS.A. McQuillinA. MoranJ.L. MowryB.J. NöthenM.M. OphoffR.A. OwenM.J. PalotieA. PatoC.N. PetryshenT.L. PosthumaD. RietschelM. RileyB.P. RujescuD. SklarP. St ClairD. WaltersJ.T.R. WergeT. SullivanP.F. O’DonovanM.C. SchererS.W. NealeB.M. SebatJ. Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects.Nat. Genet.2017491273510.1038/ng.372527869829
     [Google Scholar]
  50. WangH. GongP. ChenT. GaoS. WuZ. WangX. LiJ. MarjaniS.L. CostaJ. WeissmanS.M. QiF. PanX. LiuL. Colorectal cancer stem cell states uncovered by simultaneous single-cell analysis of transcriptome and telomeres.Adv. Sci.202188200432010.1002/advs.20200432033898197
     [Google Scholar]
  51. LiB. ChenH. YangS. ChenF. XuL. LiY. LiM. ZhuC. ShaoF. ZhangX. DengC. ZengL. HeY. ZhangC. Advances in immunology and immunotherapy for mesenchymal gastrointestinal cancers.Mol. Cancer20232217110.1186/s12943‑023‑01770‑637072770
     [Google Scholar]
  52. ZhuoJ. ChenS. FisherT.S. Process of preparing a PD-1/PD-L1 inhibitor.US Patent 202304068522023
  53. ZhouJ. Anti-PD-L1 antibody and use thereof.US Patent 202304069362023
  54. BagaevA. KotlovN. NomieK. SvekolkinV. GafurovA. IsaevaO. OsokinN. KozlovI. FrenkelF. GancharovaO. AlmogN. TsiperM. AtaullakhanovR. FowlerN. Conserved pan-cancer microenvironment subtypes predict response to immunotherapy.Cancer Cell2021396845865.e710.1016/j.ccell.2021.04.01434019806
     [Google Scholar]
  55. LiW. ZhangX. ZhangC. YanJ. HouX. DuS. ZengC. ZhaoW. DengB. McCombD.W. ZhangY. KangD.D. LiJ. CarsonW.E.III DongY. Biomimetic nanoparticles deliver mRNAs encoding costimulatory receptors and enhance T cell mediated cancer immunotherapy.Nat. Commun.2021121726410.1038/s41467‑021‑27434‑x34907171
     [Google Scholar]
  56. KraehenbuehlL. WengC.H. EghbaliS. WolchokJ.D. MerghoubT. Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways.Nat. Rev. Clin. Oncol.2022191375010.1038/s41571‑021‑00552‑734580473
     [Google Scholar]
  57. JinM.Z. JinW.L. The updated landscape of tumor microenvironment and drug repurposing.Signal Transduct. Target. Ther.20205116610.1038/s41392‑020‑00280‑x32843638
     [Google Scholar]
  58. LiX. WenesM. RomeroP. HuangS.C.C. FendtS.M. HoP.C. Navigating metabolic pathways to enhance antitumour immunity and immunotherapy.Nat. Rev. Clin. Oncol.201916742544110.1038/s41571‑019‑0203‑730914826
     [Google Scholar]
  59. XiaL. OyangL. LinJ. TanS. HanY. WuN. YiP. TangL. PanQ. RaoS. LiangJ. TangY. SuM. LuoX. YangY. ShiY. WangH. ZhouY. LiaoQ. The cancer metabolic reprogramming and immune response.Mol. Cancer20212012810.1186/s12943‑021‑01316‑833546704
     [Google Scholar]
  60. AndersonP. AptsiauriN. Ruiz-CabelloF. GarridoF. HLA class I loss in colorectal cancer: Implications for immune escape and immunotherapy.Cell. Mol. Immunol.202118355656510.1038/s41423‑021‑00634‑733473191
     [Google Scholar]
  61. AptsiauriN. GarridoF. The challenges of HLA class I loss in cancer immunotherapy: Facts and hopes.Clin. Cancer Res.202228235021502910.1158/1078‑0432.CCR‑21‑350135861868
     [Google Scholar]
  62. SchrockA.B. OuyangC. SandhuJ. SokolE. JinD. RossJ.S. MillerV.A. LimD. AmanamI. ChaoJ. CatenacciD. ChoM. BraitehF. KlempnerS.J. AliS.M. FakihM. Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer.Ann. Oncol.20193071096110310.1093/annonc/mdz13431038663
     [Google Scholar]
  63. ZhongW. ZhongH. ZhangF. HuangC. LinY. HuangJ. Characterization of hypoxia-related molecular subtypes in clear cell renal cell carcinoma to aid immunotherapy and targeted therapy via multi-omics analysis.Front. Mol. Biosci.2021868405010.3389/fmolb.2021.68405034250018
     [Google Scholar]
  64. CuiK. YaoS. ZhangH. ZhouM. LiuB. CaoY. FeiB. HuangS. HuangZ. Identification of an immune overdrive high-risk subpopulation with aberrant expression of FOXP3 and CTLA4 in colorectal cancer.Oncogene202140112130214510.1038/s41388‑021‑01677‑w33627780
     [Google Scholar]
  65. LeiZ.N. TengQ.X. TianQ. ChenW. XieY. WuK. ZengQ. ZengL. PanY. ChenZ.S. HeY. Signaling pathways and therapeutic interventions in gastric cancer.Signal Transduct. Target. Ther.20227135810.1038/s41392‑022‑01190‑w36209270
     [Google Scholar]
  66. MirzaM.R. ChaseD.M. SlomovitzB.M. dePont ChristensenR. NovákZ. BlackD. GilbertL. SharmaS. ValabregaG. LandrumL.M. HankerL.C. StuckeyA. BoereI. GoldM.A. AuranenA. PothuriB. CibulaD. McCourtC. RaspagliesiF. ShahinM.S. GillS.E. MonkB.J. BuscemaJ. HerzogT.J. CopelandL.J. TianM. HeZ. StevensS. ZografosE. ColemanR.L. PowellM.A. Dostarlimab for primary advanced or recurrent endometrial cancer.N. Engl. J. Med.2023388232145215810.1056/NEJMoa221633436972026
     [Google Scholar]
  67. WangJ. XiuJ. FarrellA. BacaY. AraiH. BattaglinF. KawanishiN. SoniS. ZhangW. MillsteinJ. ShieldsA.F. GrotheyA. WeinbergB.A. MarshallJ.L. LouE. KhushmanM. SohalD.P.S. HallM.J. LiuT. OberleyM. SpetzlerD. KornW.M. ShenL. LenzH.J. Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: A retrospective cohort study.Lancet Oncol.202324215116110.1016/S1470‑2045(22)00783‑536681091
     [Google Scholar]
  68. ZhengH. LiuH. LiH. DouW. WangJ. ZhangJ. LiuT. WuY. LiuY. WangX. Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in colorectal cancer.Stem Cell Res. Ther.202213124410.1186/s13287‑022‑02913‑035681225
     [Google Scholar]
  69. LiuB. FangX. KwongD.L.W. ZhangY. VerhoeftK. GongL. ZhangB. ChenJ. YuQ. LuoJ. TangY. HuangT. LingF. FuL. YanQ. GuanX.Y. Targeting TROY-mediated P85a/AKT/TBX3 signaling attenuates tumor stemness and elevates treatment response in hepatocellular carcinoma.J. Exp. Clin. Cancer Res.202241118210.1186/s13046‑022‑02401‑635610614
     [Google Scholar]
  70. ZhangW. ChenY. LiM. CaoS. WangN. ZhangY. WangY. A PDA-functionalized 3D lung scaffold bioplatform to construct complicated breast tumor microenvironment for anticancer drug screening and immunotherapy.Adv. Sci.20231026230285510.1002/advs.20230285537424037
     [Google Scholar]
  71. FengR.M. ZongY.N. CaoS.M. XuR.H. Current cancer situation in China: Good or bad news from the 2018 global cancer statistics?Cancer Commun.201939111210.1186/s40880‑019‑0368‑631030667
     [Google Scholar]
  72. MarkhamA. Savolitinib: First approval.Drugs202181141665167010.1007/s40265‑021‑01584‑034455538
     [Google Scholar]
  73. WangZ. DanW. ZhangN. FangJ. YangY. Colorectal cancer and gut microbiota studies in China.Gut Microbes2023151223636410.1080/19490976.2023.223636437482657
     [Google Scholar]
  74. LeiZ.N. TianQ. TengQ.X. WurpelJ.N.D. ZengL. PanY. ChenZ.S. Understanding and targeting resistance mechanisms in cancer.MedComm202343e265
     [Google Scholar]
  75. LiuZ. ZhengN. LiJ. LiC. ZhengD. JiangX. GeX. LiuM. LiuL. SongZ. BaoL. ZhanY. GaoX. N6-methyladenosine-modified circular RNA QSOX1 promotes colorectal cancer resistance to anti-CTLA-4 therapy through induction of intratumoral regulatory T cells.Drug Resist. Updat.20226510088610.1016/j.drup.2022.10088636370665
     [Google Scholar]
  76. SaeedH. LeibowitzB.J. ZhangL. YuJ. Targeting Myc-driven stress addiction in colorectal cancer.Drug Resist. Updat.20236910096310.1016/j.drup.2023.10096337119690
     [Google Scholar]
/content/journals/pra/10.2174/0115748928295346240406185103
Loading
NIFK, a Potential Prognostic and Immunological Biomarker in Pan-Cancer Analysis, Significantly Regulates Proliferation and Metastasis of Colorectal Cancer
Recent Patents on Anti-Cancer Drug Discovery 20, 601 (2025); https://doi.org/10.2174/0115748928295346240406185103
/content/journals/pra/10.2174/0115748928295346240406185103
/content/journals/pra/10.2174/0115748928295346240406185103
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Research Article
Keyword(s): bioinformatics analysis; biomarker; immunotherapy; NIFK; pan-cancer; prognosis

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test